Chart of Day: Salesforce (CRM) – 5/31 (SYM: CRM) plummeted from about $2780 to $217.47 with a first quarter revenue miss. But it appears the pullback is overdone, according to analysts.

For example, “We continue to view GenAI as a tailwind for Salesforce, with benefits likely coming in CY25,” Morgan Stanley analyst Keith Weiss said, as quoted by CNBC. Weiss reiterated an overweight rating on Salesforce, with a $320 per share price target.


Goldman Sachs reiterated a buy rating on the stock, with a price target of $315. 

JPMorgan analyst Mark Murphy said the sell-off in Salesforce stock is “overdone,” and that investors are largely overlooking the company’s still-strong free cash flow generation and its unchanged full-year forecast as well as 2025 estimates. The analyst reiterated an overweight rating on the stock with a $300 per share price target, added CNBC.

While we agree with the analysts on the pullback being overdone, wait for confirmation of trend change before jumping into the stock. The last thing you want to do now is get cut by the stock’s falling knife prior to it firmly bottoming out.

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.